Poor sleep quality and lipid profile in a rural cohort (The Baependi Heart Study)

Carregando...
Imagem de Miniatura
Citações na Scopus
22
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE BV
Autores
PAULA, Lilian K. de
OLIVEIRA, Camila Maciel
BEIJAMINI, Felipe
SCHANTZ, Malcolm von
KNUTSON, Kristen L.
Citação
SLEEP MEDICINE, v.57, p.30-35, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Aim: To test the association between cardiometabolic risk factors and subjective sleep quality assessed by the Pittsburgh sleep quality index (PSQI), independent of obstructive sleep apnea (OSA) and sleep duration. Methods: A total of 573 participants from the Baependi Heart Study, a rural cohort from Brazil, completed sleep questionnaires and underwent polygraphy for OSA evaluation. Multivariable linear regression analysis tested the association between cardiovascular risk factors (outcome variables) and sleep quality measured by PSQI, adjusting for OSA and other potential confounders (age, sex, race, salary/wage, education, marital status, alcohol intake, obesity, smoking, hypertension, and sleep duration). Results: The sample mean age was 43 +/- 16 years, 66% were female, and mean body mass index (BMI) was 26 +/- 5 kg/m(2). Only 20% were classified as obese (BMI >= 30). Overall, 50% of participants reported poor sleep quality as defined by a PSQI score >= 5. A high PSQI score was significantly associated with higher very-low-density lipoprotein (VLDL) cholesterol levels (beta = 0.392, p = 0.012) and higher triglyceride levels (beta = 0.017, p = 0.006), even after adjustments, including the apneaehypopnea index. Further adjustments accounting for marital status, alcohol intake, and medication use did not change these findings. No significant association was observed between PSQI scores and glucose or blood pressure. According to PSQI components, sleep disturbances (beta = 1.976, p = 0.027), sleep medication use (beta = 1.121, p = 0.019), and daytime dysfunction (beta = 1.290, p = 0.024) were significantly associated with higher VLDL serum levels. Only the daytime dysfunction domain of the PSQI components was significantly associated with higher triglyceride levels (beta = 0.066, p = 0.004). Conclusion: Poorer lipid profile was independently associated with poor sleep quality, assessed by the PSQI questionnaire, regardless of a normal sleep duration and accounting for OSA and socio-economic status.
Palavras-chave
Lipids, Sleep quality, PSQI, Pittsburgh sleep quality index, Very-low density lipoprotein cholesterol, Obstructive sleep apnea
Referências
  1. Beccuti G, 2011, CURR OPIN CLIN NUTR, V14, P402, DOI 10.1097/MCO.0b013e3283479109
  2. Beihl DA, 2009, ANN EPIDEMIOL, V19, P351, DOI 10.1016/j.annepidem.2008.12.001
  3. Beijamini F, 2016, SCI REP-UK, V6, DOI 10.1038/srep39283
  4. Bertolazi AN, 2011, SLEEP MED, V12, P70, DOI 10.1016/j.sleep.2010.04.020
  5. Bidulescu A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-581
  6. Buysse DJ, 2014, SLEEP, V37, P9, DOI 10.5665/sleep.3298
  7. Buysse DJ, 1989, RES PSYCHIAT, V193, P213, DOI 10.1016/0165-1781(89)90047-4
  8. Caples SM, 2005, ANN INTERN MED, V142, P187, DOI 10.7326/0003-4819-142-3-200502010-00010
  9. Collop NA, 2007, J CLIN SLEEP MED, V3, P737
  10. de Oliveira CM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185225
  11. de Paula LKG, 2016, CHEST, V149, P92, DOI 10.1378/chest.15-0843
  12. Delezie J, 2012, FASEB J, V26, P3321, DOI 10.1096/fj.12-208751
  13. Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008
  14. Depner CM, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0507-z
  15. Drager LF, 2012, EUR HEART J, V33, P783, DOI 10.1093/eurheartj/ehr097
  16. Egan KJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011598
  17. Ekstedt M, 2004, PSYCHOSOM MED, V66, P925, DOI 10.1097/01.psy.0000145821.35453.f7
  18. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults, 2001, JAMA, V285, P2486
  19. Flemons WW, 1999, SLEEP, V22, P667
  20. Horimoto ARVR, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-9
  21. Hung HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065738
  22. Iber C, 2007, SLEEP, P59, DOI [DOI 10.1002/EJOC.201200111, 10.1002/ejoc.201200111]
  23. Iesato K, 2007, CIRC J, V71, P1293, DOI 10.1253/circj.71.1293
  24. Jennings JR, 2007, SLEEP, V30, P219, DOI 10.1093/sleep/30.2.219
  25. JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540
  26. Jun JC, 2012, AM J PHYSIOL-ENDOC M, V303, pE377, DOI 10.1152/ajpendo.00641.2011
  27. Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001
  28. Lauderdale DS, 2009, AM J EPIDEMIOL, V170, P805, DOI 10.1093/aje/kwp230
  29. Lemieux I, 2001, ARCH INTERN MED, V161, P2685, DOI 10.1001/archinte.161.22.2685
  30. Lyytikainen P, 2011, INT J OBESITY, V35, P109, DOI 10.1038/ijo.2010.113
  31. Marques DR, 2017, SLEEP HEALTH, V3, P348, DOI 10.1016/j.sleh.2017.07.004
  32. Masa JF, 2011, AM J RESP CRIT CARE, V184, P964, DOI 10.1164/rccm.201103-0428OC
  33. Nedeltcheva AV, 2014, CURR OPIN ENDOCRINOL, V21, P293, DOI 10.1097/MED.0000000000000082
  34. Petrov MER, 2013, SLEEP, V36, P1587, DOI 10.5665/sleep.3104
  35. Phillips BG, 2000, AM J PHYSIOL-HEART C, V279, pH234
  36. Resta O, 2003, J INTERN MED, V253, P536, DOI 10.1046/j.1365-2796.2003.01133.x
  37. van den Berg JF, 2008, INT J OBESITY, V32, P1083, DOI 10.1038/ijo.2008.57
  38. van Den Berg JF, 2008, PSYCHOSOM MED, V70, P1005, DOI 10.1097/PSY.0b013e318186e656
  39. 2002, J LIPID RES, V43, P2172, DOI 10.1194/JLR.M200386-JLR200